Follicle dynamics and anovulation in polycystic ovary syndrome
Open accessThe DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is the commonest cause of anovulatory infertility and menstrual cycle abnormalities, but the factors responsible for failure to select a dominant follicle remain unclear. METHOD: Source is authors' own studies and search of the relevant literature. RESULTS: Arrest of antral follicle growth is associated with an abnormal endocrine environment involving hypersecretion of luteinizing hormone and insulin (and perhaps hyperandrogenism). The net effect is secondary suppression of FSH, which leads to inhibition of maturation of otherwise healthy follicles in the cohort. There is, however, emerging evidence for an intrinsic abnormality of folliculogenesis in PCOS that affects the very earliest, gonadotrophin independent, stages of follicle development. There is an increased density of small pre-antral follicles and an increased proportion of early growing follicles. These abnormalities in anovulatory PCOS are further defined by abnormal granulosa cell proliferation and disparate growth of oocyte and surrounding granulosa cells. This suggests that the normal 'dialogue' between oocyte and granulosa cells in these early growing follicles is altered. There is evidence that abnormal, local (follicle-to-follicle) signalling of anti-Müllerian hormone may play a part in disordered folliculogenesis, but it is plausible that other local regulators that have been implicated in normal and abnormal pre-antral follicle development-such as insulin-like growth factors and sex steroids-have a role in aberrant folliculogenesis in PCOS. CONCLUSIONS: Significant abnormalities in the very earliest stages of folliculogenesis may be the root cause of anovulation in PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is well established that the apoptosis-induced follicular atresia of the granulosa cells (GCs) is also a key component of the failure in the dominant follicle selection [41].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Self-citationInsulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · cited 2×
“This subgroup is one that has attracted particular attention from those who are sceptical about the validity of the Rotterdam criteria (Azziz, 2006; Azziz et al., 2006), although, in our view, there is ample evidence to suggest that those women with polycystic ovaries and either estrogen-replete…”
BackgroundEhrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,881
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,516
Regulation of ovarian follicular development in primates: facts and hypotheses
GOUGEON, A. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-121 · Cited by 1,497
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Cited by
Items 201–300 of 683
Guo, Y., Liu, S., Hu, S., Li, F., & Jin, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.673284 · Cited by 37
Kawai, T., Richards, J. S., & Shimada, M. (2021) · Communications Biology · doi:10.1038/s42003-021-02849-w · Cited by 37
Developmental Programming of Ovarian Functions and Dysfunctions
Puttabyatappa, M., & Padmanabhan, V. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.01.017 · Cited by 37
Qi, X., Pang, Y., & Qiao, J. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.01.029 · Cited by 37
Kazemi, M., Pierson, R. A., McBreairty, L. E., Chilibeck, P. D., Zello, G. A., & Chizen, D. R. (2020) · Clinical Endocrinology · doi:10.1111/cen.14179 · Cited by 36
Polycystic Ovary Syndrome in Adolescents
Witchel, S. F., Roumimper, H., & Oberfield, S. E. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.01.004 · Cited by 36
Yıldız, B. O., & Azziz, R. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.058 · Cited by 36
Yu, T., Wu, D., Cao, Y., & Zhai, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.740377 · Cited by 36
Liu, X., Yang, Y. J., Tang, C. L., Wang, K., Chen, J.-J., Teng, X., Ruan, Y. C., & Yang, J. Z. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.09.022 · Cited by 36
Choi, J. H., Seok, J., Lim, S. M., Kim, T. H., & Kim, G. J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02002-0 · Cited by 36
Calcaterra, V., Magenes, V. C., Massini, G., De Sanctis, L., Fabiano, V., & Zuccotti, G. (2024) · Nutrients · doi:10.3390/nu16070938 · Cited by 35
“Furthermore, there is often insufficient rise in follicle-stimulating hormone (FSH), leading to decreased conversion of androgen to estradiol and arrest of follicular growth [36].”
BackgroundMulti-ancestry genome-wide association analyses of polycystic ovary syndrome
Zhao, H., Xu, Y., Xue, B., Zhao, S., Zhang, M., Wu, X., Wang, T., Wen, Y., Li, S., Zhang, Q., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02393-x · Cited by 36
Gaytán, F., Morales, C., León, S., García-Galiano, D., Roa, J., & Tena‐Sempere, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144099 · Cited by 35
Choi, D.-H., Lee, W.-S., Won, M., Park, M., Park, H.-O., Kim, E., Lee, K.-A., & Bae, J. (2010) · Journal of Proteome Research · doi:10.1021/pr100008e · Cited by 35
Physiology and Pathology of the Female Reproductive Axis
Bulun, S. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00017-4 · Cited by 34
Industrial endocrine disruptors and polycystic ovary syndrome
Palioura, E., & Diamanti‐Kandarakis, E. (2013) · Journal of Endocrinological Investigation · doi:10.1007/bf03346762 · Cited by 34
Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome
Wang, Y., Wu, J., Zhang, G., Shi, Y., Meng, Y., Lv, P., Huang, W., Su, Y., Zhou, Z., Wang, B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62951-z · Cited by 34
Harris, R. A., McAllister, J. M., & Strauss, J. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310611 · Cited by 34
Association between human SHBG gene polymorphisms and risk of PCOS: a meta-analysis
Li, Y., Fang, L., Yan, Y., Wang, Z., Wu, Z., Jia, Q., Cheng, J., & Sun, Y. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.10.003 · Cited by 34
Cholesterol metabolism is decreased in patients with diminished ovarian reserve
Yang, X., Zhao, Z., Fan, Q., Li, H., Zhao, L., Liu, C., & Liang, X. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.09.013 · Cited by 34
The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review
Merlo, E., Silva, I. V., Cardoso, R. C., & Graceli, J. B. (2018) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2018.1496214 · Cited by 33
Maliqueo, M. A., Benrick, A., Alvi, A., Johansson, J., Sun, M., Labrie, F., Ohlsson, C., & Stener‐Victorin, E. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.04.026 · Cited by 33
Role of Androgen Receptor for Reconsidering the “True” Polycystic Ovarian Morphology in PCOS
Gao, X., Liu, Y., Lv, Y., Huang, T., Lü, G., Liu, H., & Zhao, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-65890-5 · Cited by 33
Vascular contributions to early ovarian development: potential roles of VEGFA isoforms
McFee, R. M., & Cupp, A. S. (2012) · Reproduction Fertility and Development · doi:10.1071/rd12134 · Cited by 33
Occurrence of multi-oocyte follicles in aquaporin 8-deficient mice
Su, W., Guan, X., Zhang, D., Sun, M., Yang, L., Yi, F., Feng, H., Feng, X., & Ma, T. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-88 · Cited by 33
Li, Y., Deng, B., Ouyang, N., Yuan, P., Zheng, L., & Wang, W. (2017) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-0929-z · Cited by 32
“While in PCOS patients, abnormal follicular development [29], genetic factors, hormone regulation, regulatory factors in the ovary, and cell apoptosis could also affect their oocyte quality [30].”
BackgroundFalbo, A. I., Rocca, M. L., Russo, T., D'Ettore, A., Tolino, A., Zullo, F., Orio, F., & Palomba, S. (2010) · Journal of Ovarian Research · doi:10.1186/1757-2215-3-16 · Cited by 32
Patil, K., Yelamanchi, S. D., Kumar, M., Hinduja, I. N., Prasad, T. S. K., Gowda, H., & Mukherjee, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214742 · Cited by 32
Erbb4 regulates the oocyte microenvironment during folliculogenesis
Veikkolainen, V., Ali, N., Doroszko, M., Kiviniemi, A., Miinalainen, I., Ohlsson, C., Poutanen, M., Rahman, N., Elenius, K., Vainio, S. J., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa161 · Cited by 31
Wu, Z., Fang, L., Li, Y., Yan, Y., Thakur, A., Cheng, J., & Sun, Y. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13407 · Cited by 31
Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Papadakis, E. P., Kandaraki, E., & Panidis, D. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.743005 · Cited by 31
Sundvall, L., Kirkegaard, K., Ingerslev, H. J., & Knudsen, U. B. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0488-0 · Cited by 31
Nesfatin-1 levels and metabolic markers in polycystic ovary syndrome
Alp, E., Görmüş, U., Güdücü, N., & Bozkurt, S. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1024219 · Cited by 32
Leonhardt, H., Hellström, M., Gull, B., Lind, A., Nilsson, L., Janson, P. O., & Stener‐Victorin, E. (2015) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12571 · Cited by 30
Wang, Y., He, J., & Yang, J. (2018) · Medical Science Monitor · doi:10.12659/msm.909098 · Cited by 30
Ding, H.-M., Xiang, Y., Zhu, Q., Wu, H., Xu, T., Huang, Z., & Ge, H. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104078 · Cited by 30
Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
Pugliese, G., de Alteriis, G., Muscogiuri, G., Barrea, L., Verde, L., Zumbolo, F., Colao, A., & Savastano, S. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02084-6 · Cited by 29
Anti-Müllerian Hormone and Ovarian Morphology in Women With Hypothalamic Hypogonadism
Alemyar, A., van der Kooi, A.-L., & Laven, J. S. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa116 · Cited by 29
Prenatal androgen exposure affects ovarian lipid metabolism and steroid biosynthesis in rats
Abruzzese, G. A., Heber, M. F., Ferreira, S. R., Ferrer, M. J., & Motta, A. B. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0304 · Cited by 29
Yang, M., Li, J., An, Y., & Zhang, S. (2015) · Tissue and Cell · doi:10.1016/j.tice.2015.06.003 · Cited by 29
Roles of follicle stimulating hormone and its receptor in human metabolic diseases and cancer.
Sun, D., Bai, M., Jiang, Y., Hu, M., Wu, S., Zheng, W., & Zhang, Z. (2020) · PubMed Central · Cited by 29
Marcondes, R. R., Carvalho, K. C., Duarte, D. C., Garcia, N., do Amaral, V. C., Simões, M. D. J., Turco, E. G. L., Soares, J. M., Baracat, E. C., & Maciel, G. A. R. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.01.006 · Cited by 29
Bahadur, A., Verma, N., Mundhra, R., Chawla, L., Ajmani, M., Sri, M. S., & Arora, S. (2021) · Cureus · doi:10.7759/cureus.16047 · Cited by 29
Izadi, M., Rezvani, M. E., Aliabadi, A., Karimi, M., & Aflatoonian, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1021581 · Cited by 29
Liu, Y., Zhu, J., Yang, Y., Chen, Z., Zhou, Y. F., Fei, W., Zhang, X., & Zheng, Y. (2025) · Journal of Biological Engineering · doi:10.1186/s13036-025-00533-9 · Cited by 29
Prenatal programming by testosterone of follicular theca cell functions in ovary
Monniaux, D., Genêt, C., Maillard, V., Jarrier-Gaillard, P., Adriaensen, H., Hennequet‐Antier, C., Lainé, A.-L., Laclie, C., Papillier, P., Plisson‐Petit, F., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03230-1 · Cited by 29
Zheng, L., Chen, P.-F., Dai, W., Zheng, Z., & Wang, H. (2022) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-022-3582-z · Cited by 29
Neonatal exposure to xenoestrogens impairs the ovarian response to gonadotropin treatment in lambs
Rivera, O. E., Varayoud, J., Rodriguez, H. A., Santamaría, C. G., Bosquiazzo, V. L., Osti, M. R., Belmonte, N. M., Muñoz‐de‐Toro, M., & Luque, E. H. (2015) · Reproduction · doi:10.1530/rep-14-0567 · Cited by 28
Fábregues, F., Castelo‐Branco, C., Carmona, F., Guimerà, M., Casamitjana, R., & Balasch, J. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487595 · Cited by 28
Hormone-Like Effects of 4-Vinylcyclohexene Diepoxide on Follicular Development
Cao, L. B., Liu, H., Lü, G., Lv, Y., Leung, C. K., Du, Y. Z., Wang, W. M., Xiong, Z. Q., Su, X. W., Li, H. J., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00587 · Cited by 28
Fong, S. L., Schipper, I., de Jong, F. H., Themmen, A. P. N., Visser, J. A., & Laven, J. S. E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.084 · Cited by 28
Parua, S., Purkait, M. P., Bhattacharjee, A., Thangarajan, R., Subramanian, R., Islam, K., Bhattacharya, K., & Syamal, A. K. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100619 · Cited by 27
Genetic basis of polycystic ovary syndrome
Barber, T., & Franks, S. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.32 · Cited by 27
Self-citationVaspin, a novel adipokine in woman granulosa cells physiology and PCOS pathogenesis?
Bongrani, A., Mellouk, N., Ramé, C., Cornuau, M., Guérif, F., Froment, P., & Dupont, J. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0550 · Cited by 27
Unraveling the complexity of polycystic ovary syndrome with animal models
Liu, H., Tu, M., Yin, Z., Zhang, D., Ma, J., & He, F. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.09.012 · Cited by 27
Ghaneei, A., Jowkar, A., Ghavam, M. R. H., & Ghaneei, M. E. (2015) · Europe PMC (PubMed Central) · Cited by 27
Cai, W.-Y., Luo, X., Song, J., Ji, D., Zhu, J., Duan, C., Wu, W., Wu, X., & Xu, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.736320 · Cited by 27
Franks, S. (2009) · Medicine · doi:10.1016/j.mpmed.2009.06.013 · Cited by 26
Self-citationde Resende, L. O. T., dos Reis, R. M., Ferriani, R. A., Vireque, A. A., Santana, L. F., Silva, A. C. J. D. S. R. E., & Martins, W. P. (2010) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032010000900006 · Cited by 26
Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome
Papaetis, G. S., Filippou, P. K., Constantinidou, K. G., & Stylianou, C. S. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00942-2 · Cited by 25
Yalamanchi, S. K., Sam, S., Cardenas, M. O., Holaday, L. W., Urbanek, M., & Dunaif, A. E. (2012) · Obesity · doi:10.1038/oby.2011.400 · Cited by 25
O’Neill, K. E., Senapati, S., & Dokras, A. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.09.042 · Cited by 25
Yang, K., Zeng, L., Bao, T., Long, Z., & Jin, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-54408-3 · Cited by 25
Yang, W., Ma, Y., Wu, Y., Lei, X., Zhang, J., & Li, M. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-024-01563-5 · Cited by 25
Pro12Ala and His447His polymorphisms of PPAR-γ are associated with polycystic ovary syndrome
Gu, B., & Baek, K. (2009) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60008-9 · Cited by 25
Modelling female reproductive function in farmed animals
Vetharaniam, I., Peterson, A. J., McNatty, K. P., & Soboleva, T. K. (2010) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2010.08.015 · Cited by 24
Owens, L. A., & Franks, S. (2025) · Reproduction · doi:10.1530/rep-24-0485 · Cited by 24
Self-citationPolycystic ovarian syndrome in adolescents: From diagnostic criteria to therapeutic management.
Nicolaides, N. C., Matheou, A., Vlachou, F., Neocleous, V., & Skordis, N. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i3.10162 · Cited by 24
Olaniyan, O. T., Okoli, B. J., Adetunji, C. O., Priscilla, B., Adebayo, F., Dare, A., Okotie, G. E., Ibitoye, B. O., Eweoya, O. O., & Mali, P. C. (2020) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2019-0076 · Cited by 24
Dysfunction of Human Estrogen Signaling as a Novel Molecular Signature of Polycystic Ovary Syndrome
Marie, C., Pierre, A., Mayeur, A., Giton, F., Corre, R., Grynberg, M., Cohen-Tannoudji, J., Guigon, C. J., & Chauvin, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316689 · Cited by 24
Weintraub, A., Margalioth, E. J., Chetrit, A. B., Gal, M., Goldberg, D., Alerhand, S., & Eldar‐Geva, T. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.02.020 · Cited by 24
Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome
Lauria, P. B. M., Del Puerto, H. L., Reis, A. M., Candido, A. L., & Reis, F. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2141 · Cited by 23
“Because PCOS is an important cause of anovulatory infertility due to abnormalities of folliculogenesis (4, 6), we can hypothesize that low serum ANP contributes to the ovulatory dysfunction in this syndrome.”
BackgroundKhatun, M., Lundin, K., Naillat, F., Loog, L., Saarela, U., Tuuri, T., Salumets, A., Piltonen, T., & Tapanainen, J. S. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10627-w · Cited by 23
Shaikh, N. J., Dadachanji, R., Meherji, P. K., Shah, N. S., & Mukherjee, S. (2015) · Gene · doi:10.1016/j.gene.2015.11.033 · Cited by 23
Wong, F. C. K., Chan, A. Z., Wong, W. S., Kwan, A. H. W., Law, T. S. M., Chung, J. P. W., Kwok, J. S.-S., & Chan, A. O.-K. (2019) · Case Reports in Endocrinology · doi:10.1155/2019/9237459 · Cited by 23
The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
Kolnikaj, T. S., Herman, R., Janež, A., & Jensterle, M. (2024) · Medicina · doi:10.3390/medicina60020244 · Cited by 23
Jarrett, B. Y., Vantman, N., Mergler, R. J., Brooks, E. D., Pierson, R. A., Chizen, D. R., & Lujan, M. E. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00112 · Cited by 23
Zhou, W., Zhang, T., Lian, Y., Zhang, W., Yang, M., Li, Y., Wang, L., & Yan, X. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.01.007 · Cited by 23
Christodoulaki, A., He, H., Zhou, M., Barberán, A. C., Roo, C. D., Lopes, S. M. C. D. S., Baetens, M., Menten, B., Soom, A. V., Sutter, P. D., et al. (2023) · Human Reproduction · doi:10.1093/humrep/dead068 · Cited by 23
Compromised Cumulus-Oocyte Complex Matrix Organization and Expansion in Women with PCOS
Patil, K., Shinde, G., Hinduja, I. N., & Mukherjee, S. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00775-0 · Cited by 23
Cellular senescence of granulosa cells in the pathogenesis of polycystic ovary syndrome
Tanaka, T., Urata, Y., Harada, M., Kunitomi, C., Kusamoto, A., Koike, H., Xu, Z., Sakaguchi, N., Tsuchida, C., Komura, A., et al. (2024) · Molecular Human Reproduction · doi:10.1093/molehr/gaae015 · Cited by 22
Li, S., Zhai, J., Liu, J., Di, F., Sun, Y. W., Li, W., Chen, Z., & Du, Y. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.046 · Cited by 22
Myostatin: a multifunctional role in human female reproduction and fertility – a short review
Wang, S., Fang, L., Cong, L., Chung, J. P. W., Li, T. C., & Chan, D. Y. L. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00969-4 · Cited by 22
Albaghdadi, A. J. H., Feeley, C. A., & Kan, F. W. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-42960-x · Cited by 22
Adult Female Acne: Recent Advances in Pathophysiology and Therapeutic Approaches
Amuzescu, A., Tampa, M. Ş., Matei, C., & Georgescu, S. R. (2024) · Cosmetics · doi:10.3390/cosmetics11030074 · Cited by 22
Abizadeh, M., Novin, M. G., Amidi, F., Ziaei, S. A., Abdollahifar, M., & Nazarian, H. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00168-9 · Cited by 22
Downregulated Expression of Peroxiredoxin 4 in Granulosa Cells from Polycystic Ovary Syndrome
Meng, Y., Qian, Y., Gao, L., Cai, L., Cui, Y., & Liu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076460 · Cited by 22
Xu, J., McGee, W. K., Bishop, C. V., Park, B. S., Cameron, J. L., Zelinski, M. B., & Stouffer, R. L. (2014) · Endocrinology · doi:10.1210/en.2014-1711 · Cited by 21
Rasheed, N., Ahmed, A., Nosheen, F., Imran, A., Islam, F., Noreen, R., Chauhan, A., Shah, M. A., & Ali, Y. A. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3328 · Cited by 21
Xu, T., Xiang, Y., Huang, Z., Zhu, Q., Wu, H., Cai, J., Weng, L., & Ge, H. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01757-5 · Cited by 21
Kim, Y. J., Kim, Y. Y., Kang, B.-C., Kim, M. S., Ko, I. K., Liu, H. C., Rosenwaks, Z., & Ku, S. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2214 · Cited by 21
Role of EGFR expressed on the granulosa cells in the pathogenesis of polycystic ovarian syndrome
Zhang, J.-H., Zhan, L., Zhao, M.-Y., Wang, J., Xie, F., Xu, Z., Xu, Q., Cao, Y., & Liu, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.971564 · Cited by 21
Wei, L., Li, L., Fang, C., Huang, R., & Liang, X. (2013) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-0041-y · Cited by 21
Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives
Xu, Y., Zhou, Z., Pan, J., & Huang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.936948 · Cited by 20
Insulin resistance influences central opioid activity in polycystic ovary syndrome
Berent‐Spillson, A., Love, T., Pop‐Busui, R., Sowers, M. R., Persad, C. C., Pennington, K. P., Eyvazzadeh, A. D., Padmanabhan, V., Zubieta, J., & Smith, Y. R. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.03.031 · Cited by 20
Abbott, D. H., Vepraskas, S. H., Horton, T. H., Terasawa, E., & Levine, J. E. (2018) · Neuroendocrinology · doi:10.1159/000490570 · Cited by 20
Yang, D., Li, N., Ma, A., Dai, F., Zheng, Y., Hu, X., Wang, Y., Xian, S., Zhang, L., Yuan, M., et al. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00352-x · Cited by 20
Multiomics Analysis–Based Biomarkers in Diagnosis of Polycystic Ovary Syndrome
Rani, S., & Chandna, P. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00863-9 · Cited by 20
Sumji, S. A., Bhat, A., Rashid, A., Bashir, R., Wani, I. A., Vasudevan, V., Sehar, T., & Ganie, M. A. (2022) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-022-01058-4 · Cited by 20
Lee, J. Y., Tae, J. C., Kim, C. H., Hwang, D., Kim, K. C., Suh, C. S., & Kim, S. H. (2017) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2017.44.3.146 · Cited by 20
Metadata
- Authors
- Franks, S., Stark, J., & Hardy, K.
- Affiliations
- Hammersmith Hospital (GB)
- Imperial College London (GB)
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04-02
- Volume
- 14
- Issue
- 4
- Pages
- 367-378
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2125717115
- Cited by
- 581
- References
- 130
- Citations by year
- 2026: 27 · 2025: 44 · 2024: 39 · 2023: 52 · 2022: 48 · 2021: 40 · 2020: 41 · 2019: 35 · 2018: 28 · 2017: 24 · 2016: 32 · 2015: 32 · 2014: 24 · 2013: 36 · 2012: 32
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Human Reproduction Update (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, anovulation, folliculogenesis, dominant follicle selection, insulin resistance, FSH suppression, preantral follicles, granulosa cell proliferation, oocyte-granulosa cell communication, anti-Müllerian hormone, insulin-like growth factor, sex steroids, anovulatory infertility
- MeSH terms
- Anovulation, Female, Ovarian Follicle, Humans, Insulin Resistance, Models, Biological, Oocytes, Polycystic Ovary Syndrome, Gonadal Steroid Hormones, Somatomedins, Signal Transduction, Cell Proliferation, Anti-Mullerian Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.